When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Sarcoidosis

Last reviewed: 16 Aug 2025
Last updated: 01 Apr 2025

Summary

Definition

History and exam

Key diagnostic factors

  • cough
  • dyspnea
  • chronic fatigue
  • arthralgia
  • wheezing
  • rhonchi
  • lymphadenopathy
  • photophobia
  • red painful eye
  • blurred vision
  • erythema nodosum
  • lupus pernio
  • conjunctival nodules
  • facial palsy
Full details

Other diagnostic factors

  • absent history of exposure to beryllium
  • chest wall pain
  • hemoptysis
  • weight loss
  • low-grade fever
  • arrhythmias
  • heart block
  • hepatomegaly
  • headache
  • seizures
  • symptoms and signs of pituitary lesion
Full details

Risk factors

  • age 20-50 years
  • family history of sarcoidosis
  • Scandinavian origin
  • female sex
  • nonsmokers
  • black ancestry
  • black ancestry: uveitis
  • Puerto Rican origin: lupus pernio
  • European origin: erythema nodosum
Full details

Diagnostic tests

1st tests to order

  • chest x-ray
  • CBC
  • serum BUN
  • serum creatinine
  • liver enzymes
  • serum calcium
  • PFTs
  • ECG
  • eye exam
  • interferon gamma release assay
Full details

Tests to consider

  • serum ACE
  • CT scan of chest
  • endobronchial ultrasound-transbronchial needle aspiration
  • bronchoalveolar lavage (BAL)
  • skin biopsy
  • 24-hour urine calcium
  • gallium-67 scan
  • vitamin D
  • MRI
  • (18)F-fluorodeoxyglucose (FDG) PET scan
Full details

Emerging tests

  • 3'-deoxy-3'-[18F]-fluorothymidine (FLT) PET scan
  • 4'-[methyl-11C]-thiothymidine PET/CT scan

Treatment algorithm

ACUTE

acute respiratory failure unable to tolerate oral intake

acute respiratory failure able to tolerate oral intake

ONGOING

pulmonary disease

cutaneous disease

ocular disease

cardiovascular disease

central nervous system or peripheral nervous system involvement

renal disease

Contributors

Authors

Muthiah P. Muthiah, MD, FCCP

Acting Chief of Pulmonary, Critical Care & Sleep Medicine

VA Medical Center, Memphis

Professor & Vice Chair of Medicine

University of Tennessee Health Science Center

Memphis

TN

Declarações

MPM declares that he has no competing interests.

Amr El Gamal, MD, FCCP

Pulmonary and Critical Care

Medical Service

VA Medical Center

Martinsburg

Assistant Professor of Medicine

West Virginia University

Morgantown

WV

Declarações

AEG declares that he has served as a reviewer for the American Physician Institute.

Revisores

George Swingler, MD

Professor

School of Child and Adolescent Health

Red Cross Children's Hospital

University of Cape Town

Rondebosch

Cape Town

South Africa

Declarações

GS declares that he has no competing interests.

Kyle Hogarth, MD, FCCP

Assistant Professor of Medicine

Department of Medicine

Section of Pulmonary and Critical Care

University of Chicago

Chicago

IL

Declarações

KH declares that he has no competing interests.

Marc Judson, MD

Chief

Division of Pulmonary and Critical Care Medicine

AMC Pulmonary and Critical Care Medicine

Albany

NY

Declarações

MJ declares that he has no competing interests.

Nadera Sweiss, MD

Assistant Professor of Medicine

Section of Rheumatology

Department of Medicine

University of Chicago

Chicago

IL

Declarações

NS declares that she has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

Referências

Nossas equipes internas de editoria e de evidências trabalham em conjunto com colaboradores internacionais especializados e pares revisores para garantir que forneçamos acesso às informações o mais clinicamente relevantes possível.

Principais artigos

American Thoracic Society. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med. 1999 Aug;160(2):736-55.Texto completo  Resumo

Thillai M, Atkins CP, Crawshaw A, et al. BTS clinical statement on pulmonary sarcoidosis. Thorax. 2021 Jan;76(1):4-20.Texto completo  Resumo

Crouser ED, Maier LA, Wilson KC, et al. Diagnosis and detection of sarcoidosis. An official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2020 Apr 15;201(8):e26-51.Texto completo  Resumo

Cheng RK, Kittleson MM, Beavers CJ, et al. Diagnosis and management of cardiac sarcoidosis: a scientific statement from the American Heart Association. Circulation. 2024 May 21;149(21):e1197-216.Texto completo  Resumo

Baughman RP, Valeyre D, Korsten P, et al. ERS clinical practice guidelines on treatment of sarcoidosis. Eur Respir J. 2021 Dec;58(6):2004079.Texto completo  Resumo

Artigos de referência

Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.
  • Sarcoidosis images
  • Diagnósticos diferenciais

    • Tuberculosis
    • Histoplasmosis
    • Non-small cell lung cancer
    Mais Diagnósticos diferenciais
  • Diretrizes

    • Diagnosis and management of cardiac sarcoidosis: a scientific statement from the American Heart Association
    • ERS clinical practice guidelines on treatment of sarcoidosis
    Mais Diretrizes
  • Folhetos informativos para os pacientes

    Sarcoidosis

    Mais Folhetos informativos para os pacientes
  • padlock-lockedConectar-se ou assinar para acessar todo o BMJ Best Practice

O uso deste conteúdo está sujeito ao nosso aviso legal